ELAHERE 100 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung

7680697000014 CH-69700 Konzentrat
ELAHERE 100 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
ELAHERE 100 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
ELAHERE 100 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
16/06/2026
Summary of Product Characteristics
Français
16/06/2026
Summary of Product Characteristics
Italien
16/06/2026

Detailed composition

Substance Quantity Type Category
mirvetuximabum soravtansinum
100.0 MG Substance Wirkstoff (Principe actif)
acidum aceticum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
natrii acetas
- Substance HNIDK
natrium
2.94 MG Substance HBESI
saccharum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 3394.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2026

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
69700
Drug name
ELAHERE, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01FX26
Authorization status
Z
Dispensing category
A
First authorization
13/03/2025
Authorization expiration date
12/03/2030
IT Number
07.16.1.
Domain
Human medicine
Field of application
Ovarial-, Tuben- oder primäres Peritonealkarzinom

Package details

Description (FR)
ELAHERE 100 mg/20 ml conc perf 100 mg 1 pce
Description (DE)
ELAHERE 100 mg/20 ml Konz Inf 100 mg 1 Stk
Market launch
13/03/2025
Narcotic (BTM)
No
Buy us a coffee Explore the data